Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. New Age Recommendations for the RSV Vaccine are in Progress CDC advisers are considering lowering the recommended age for RSV vaccination in adults, a move that could expand protection for vulnerable populations. Currently approved for tho

Introduction: Multiple sclerosis (MS) is a chronic, inflammatory, and autoimmune disease of the central nervous system that affects approximately 2.9 million people worldwide (1,2). Progressive forms of MS are defined by a gradual worsening of neurological function, independent of relapses. This progression can begin from the onset, known as primar

Secondary amenorrhea is defined as the absence of menses for ≥3 cycle lengths in a person with previously regular menstrual cycles or the absence of menses for ≥ 6 months in a person with any previously irregular menses (1). It can result from various underlying conditions, including hormonal imbalances, stress, significant weight changes, or exces

Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Grants Accelerated Approval to Atrasentan for IgA Nephropathy The FDA has granted accelerated approval to atrasentan for adults with primary IgA nephropathy at risk of rapid progression. The Phase III ALIGN trial demonstrated that atra

Discover innovative healthcare strategies powered by responsible AI. Learn about transparency, bias mitigation, data privacy, and the importance of collaboration between healthcare professionals and AI developers to ensure ethical, equitable, and effective patient care solutions. Engage with the conversation and submit your questions below—an essen

The DISCOVER Trial represents a major advancement in HIV prevention research, offering valuable insight into new options for individuals at risk of HIV (1,2). Sponsored by Gilead Sciences, the trial explored how different PrEP medications perform in real-world settings, focusing on their safety, effectiveness, and user adherence( 1–3). As part of G

Hello and a Warm Welcome to MedX, In this episode, we cover the most recent FDA approvals shaping the future of medical treatments: Durvalumab – Approved for muscle-invasive bladder cancer as neoadjuvant and adjuvant therapy. Cabozantinib – Approved for pancreatic and extra-pancreatic neuroendocrine tumors in patients 12 and older. Fitusiran – Appr

Join Dipu Patel, Digital Health Consultant and AI Entrepreneur from the USA, and Dr. Avneesh Khare, AI & Emerging Tech in Medicine Consultant and Educator from India, as they explore the transformative impact of Agentic AI in healthcare. Dive into how AI is revolutionizing clinical decision-making, personalized medicine, workflow automation, and di

Hello and a Warm Welcome to MedX, Today's Updates Include: Phase 4 VESTIGE Trial Shows How Dupilumab Benefits Type 2 Asthma Patients Latest FDA Approvals Inhaled Sedation in ARDS: Phase 3 SESAR Trial Findings World Tuberculosis Day: The Challenge of Ending a Curable Disease